GHIT Fund Announces New Investments: A Total of 3.29 Billion Yen in Drugs for Malaria, Tuberculosis, Chagas Disease, Lymphatic Filariasis, and Onchocerciasis, Vaccines for Malaria, and Diagnostics for Leishmaniasis and Mycetoma - Benzinga

GHIT Fund Announces New Investments: A Total of 3.29 Billion Yen in Drugs for Malaria, Tuberculosis, Chagas Disease, Lymphatic Filariasis, and Onchocerciasis, Vaccines for Malaria, and Diagnostics for Leishmaniasis and Mycetoma  Benzinga

Comments

Popular posts from this blog

Amring Pharmaceuticals Inc. Announces the Launch of Timolol ... - businesswire.com

Creon: Dosage, side effects, alternatives, cost, uses, and more - Medical News Today

Major U.S. retailers limit infant formula purchases on shortage - Reuters